Inflarx N.V. (($IFRX)) announced an update on their ongoing clinical study. Study Overview: The JUST BREATHE study, ...
First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, (GLOBE ...
Lady Purple was awarded Gold during the latest Pure Beauty Awards 2025 as the Best New Ingredient. This article dives deep ...
Patients gain hope through regenerative medicine doctors earn empowerment and recognition and India gains economic momentum through reduced chronic burden and enhanced GDP growth.Dr. Polisetty ...
When ultra-rich investors start coalescing into the same names or put an unusually large amount of money into a single stock, ...
Learn more about whether Alkermes plc or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Alps Group Inc (the “ Company ” or “ Alps Group ”), the parent company of Alps Life Sciences Inc. (“ Alps Holdco ”), a fully integrated biotechnology research and healthcare platform specializing in ...
The Russell 2500 Index was up 9.00%. The Wasatch Long/Short Alpha Fund—Investor Class did not keep pace and finished the ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results